To: Tom Gebing who wrote (21944 ) 6/8/1999 10:07:00 AM From: Cooney1 Respond to of 93625
Price Target of $150, with short interest at 6.1 Million Shares. This won't help the shorts: 01:48am EDT 8-Jun-99 Morgan Stanley\DW (Edelstone/Cross/Gerhardy) RMBS INTC RAMBUS : MICRON HAS FINALLY JUMPED ON THE RAMBUS BANDWAGON Rambus (RMBS): Micron Has Finally Jumped On The Rambus Bandwagon Mark Edelstone/John Cross/Louis Gerhardy (415) 576-2381 Date: June 8, 1999 Industry: Semiconductors Type: Company Update ______________________________________________________________________ Rating: Strong Buy Price: $77 7/8 52-wk Range: $110-$36 Price Target: $150 ______________________________________________________________________ FY Ends ----EPS---- ----CYEPS---- Rel. P/E Sept Curr Prior P/E Curr Prior P/CYE (S&P 500) 98A $0.28 278.1x $0.30 259.6x 620% 99E $0.32 243.4x $0.34 229.1x 633% 00E $0.80 97.4x $1.20 64.9x 195% ______________________________________________________________________ Qtrly ---- 1Q ---- ---- 2Q ---- ---- 3Q ---- ---- 4Q ---- EPS Curr Prior Curr Prior Curr Prior Curr Prior 98A $0.06 $0.07 $0.07 $0.07 99E $0.08A $0.08A $0.08 $0.08 00E $0.08 $0.11 $0.23 $0.38 ______________________________________________________________________ 5 Yr. EPS Growth: 75% Debt to Cap.: 0.1% Dividend: None Mkt Cap./Rev: NM Shares Outst.: 25.0 MM Mkt Cap.: $1,947 MM ______________________________________________________________________ KEY POINTS - After the market closed yesterday, Micron Technology ($40 1/4) announced that it has delivered samples of its 128Mb and 144Mb Rambus DRAMs to Intel. - We believe that yesterday's press release from Micron marks one of the first positive announcements that the company has ever made about its commitment to Rambus. Micron currently expects to have fully qualified Rambus DRAMs in volume production in the second half of this year. - Samsung, NEC, Hyundai, Toshiba, and Siemens all appear to be further along in their deployment of Rambus's DRAM technology than Micron. However, we believe that Micron's strong financial position, technology leadership, and ability to aggressively ramp up its 0.18- micron process technology should eventually enable the company to become one of the leading suppliers of Rambus DRAMs. - We believe that Intel ($53 1/2, Strong Buy) is solidly on schedule to introduce its 820 chipset (code named Camino) and support the launch of Rambus DRAM-based PCs in September. We believe that RMBS offers significant upside potential in the near and long term, and Micron's support should be viewed as a near-term psychological positive for the stock. The information and opinions in this report were prepared by Morgan Stanley & Co. Incorporated ("Morgan Stanley Dean Witter"). Morgan Stanley Dean Witter does not undertake to advise you of changes in its opinion or information. Morgan Stanley Dean Witter and others associated with it may make markets or specialize in, have positions in and effect transactions in securities of companies mentioned and may also perform or seek to perform investment banking services for those companies. Within the last three years, Morgan Stanley & Co. Incorporated, Dean Witter Reynolds Inc. and/or their affiliates managed or co-managed a public offering of the securities of Rambus and Intel. Morgan Stanley & Co. Incorporated, Dean Witter Reynolds Inc. and/or their affiliates make a market in the securities of Rambus and Intel. Morgan Stanley & Co. Incorporated, Dean Witter Reynolds Inc. and/or their affiliates or their employees have or may have a long or short position or holding in the securities, options on securities, or other related investments of issuers mentioned herein. The investments discussed or recommended in this report may be unsuitable for investors depending on their specific investment objectives and financial position. Where an investment is denominated in a currency other than the investor's currency, changes in rates of exchange may have an adverse effect on the value, price of, or income derived from the investment. Past performance is not necessarily a guide to future performance. Income from investments may fluctuate. The price or value of the investments to which this report relates, either directly or indirectly, may fall or rise against the interest of investors. To our readers in Australia: This publication has been issued by Morgan Stanley & Co. Inc. but is being distributed in Australia by Morgan Stanley Australia Limited, a licensed dealer, which accepts responsibility for its contents. Any person receiving this report and wishing to effect transactions in any security discussed in it may wish to do so with an authorised representative of Morgan Stanley Australia Limited. To our readers in the United Kingdom: This publication has been issued by Morgan Stanley & Co. Incorporated and approved by Morgan Stanley & Co. International Ltd., regulated by the Securities and Futures Authority Limited. Morgan Stanley & Co. International Limited and/or its affiliates may be providing or may have provided significant advice or investment services, including investment banking services, for any company mentioned in this report. The investments discussed or recommended in this report may be unsuitable for investors depending on their specific investment objectives and financial position. Private investors should obtain the advice of their Morgan Stanley & Co. International Limited representative about the investments concerned. To our readers in Spain: AB Asesores Bursatiles Bolsa SVB, S.A., a Morgan Stanley Dean Witter group company, supervised by the Spanish Securities Markets Commission (CNMV), hereby states that this document has been written and distributed in accordance with the rules of conduct applicable to financial research as established under Spanish regulations. This publication is disseminated in Japan by Morgan Stanley Japan Limited and in Singapore by Morgan Stanley Dean Witter Asia (Singapore) Pte. Additional information on recommended securities is available on request. Copyright 1999 Morgan Stanley Dean Witter & Co. First Call Corporation - all rights reserved. 617/345-2500